| |
| |
|
| Insider
Information: |
Epstein David R |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
5,146,952 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$320,479 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,146,952 |
|
|
| Total
Value |
$320,479 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.5
|
0.0
|
| Percentage
Gain/Loss : |
 59.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
International Flavors & Fragranc... |
IFF |
|
|
0 |
|
0 |
Premium* |
|
|
Rubius Therapeutics, Inc. |
RUBY |
Director |
2022-04-21 |
4,720,012 |
|
0 |
Premium* |
|
|
Axcella Health Inc. |
AXLA |
Director |
2022-05-19 |
209,756 |
2019-06-26 |
0 |
Premium* |
|
|
Evelo Biosciences Inc |
EVLO |
Director |
2022-06-30 |
93,932 |
2020-08-28 |
0 |
Premium* |
|
|
Senti Biosciences, Inc |
SNTI |
Director |
2022-06-08 |
123,252 |
2022-06-08 |
0 |
Premium* |
|
|
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2022-11-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
CEO |
• • – |
2023-12-14 |
4 |
D |
$229.00 |
$3,757,203 |
D/D |
(16,407) |
0 |
0 |
- |
|
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2020-08-28 |
4 |
B |
$4.34 |
$18,631 |
D/D |
4,248 |
4,248 |
2.39 |
% |
|
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2020-08-31 |
4 |
B |
$4.46 |
$25,804 |
D/D |
5,752 |
10,000 |
2.39 |
% |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-06-26 |
4 |
B |
$9.57 |
$138,765 |
D/D |
14,500 |
14,500 |
2.39 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-06-27 |
4 |
B |
$9.15 |
$915 |
D/D |
100 |
14,600 |
2.31 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-07-01 |
4 |
B |
$8.74 |
$8,735 |
D/D |
1,000 |
15,500 |
2.39 |
- |
|
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2020-12-11 |
4 |
B |
$6.40 |
$51,261 |
D/D |
7,700 |
17,700 |
2.39 |
% |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-07-02 |
4 |
B |
$8.77 |
$30,678 |
D/D |
3,500 |
19,000 |
2.39 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-07-03 |
4 |
B |
$8.99 |
$503 |
D/D |
56 |
19,056 |
2.31 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-06-28 |
4 |
B |
$10.04 |
$54,216 |
D/D |
5,400 |
20,000 |
2.39 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-07-08 |
4 |
B |
$9.00 |
$2,466 |
D/D |
274 |
24,830 |
2.31 |
- |
|
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2021-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,850 |
27,550 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-07-09 |
4 |
B |
$8.24 |
$34,608 |
D/D |
4,200 |
29,030 |
2.39 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-07-10 |
4 |
B |
$8.07 |
$10,669 |
D/D |
1,322 |
30,352 |
2.39 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-07-17 |
4 |
B |
$7.55 |
$7,550 |
D/D |
1,000 |
31,352 |
2.39 |
- |
|
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2021-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,927 |
32,477 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-08-01 |
4 |
B |
$6.98 |
$28,562 |
D/D |
4,092 |
35,444 |
2.39 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-08-02 |
4 |
B |
$7.04 |
$20,057 |
D/D |
2,849 |
38,293 |
2.39 |
- |
|
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2021-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,926 |
47,254 |
0 |
- |
|
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2022-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,925 |
52,179 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-11-26 |
4 |
B |
$3.55 |
$49,700 |
D/D |
14,000 |
52,293 |
2.39 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2019-11-27 |
4 |
B |
$3.91 |
$3,930 |
D/D |
1,005 |
53,298 |
2.31 |
- |
|
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,926 |
57,105 |
0 |
- |
|
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2022-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,926 |
62,031 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2020-02-27 |
4 |
B |
$3.65 |
$46,720 |
D/D |
12,800 |
66,098 |
2.39 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
